Literature DB >> 27830542

Hepatocyte Transplantation in Special Populations: Clinical Use in Children.

Zahida Khan1,2, Stephen C Strom3.   

Abstract

Orthotopic liver transplantation remains the only proven cure for end-stage liver failure. Despite significant advances in the field, the clinical demand for donor organs far outweighs the supply. Hepatocyte transplantation has been proposed as an alternative approach to whole liver transplant in select diseases. Several international centers have reported experimental trials of human hepatocyte transplantation in acute liver failure and liver-based metabolic disorders. This chapter provides an introduction to hepatocyte transplantation from both a technical and clinical perspective. We will also focus on the special needs of pediatric patients, since historically the majority of clinical hepatocyte transplants have involved infants and children.

Entities:  

Keywords:  Cell therapy; Gene therapy; Hepatocyte transplant; Human hepatocytes; Metabolic liver disease; Pediatric liver disease; Regenerative medicine

Mesh:

Year:  2017        PMID: 27830542      PMCID: PMC5125821          DOI: 10.1007/978-1-4939-6506-9_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  62 in total

1.  Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity.

Authors:  M Grossman; S E Raper; J M Wilson
Journal:  Hum Gene Ther       Date:  1992-10       Impact factor: 5.695

2.  Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes.

Authors:  Juliana Puppi; Ragai R Mitry; Michel Modo; Anil Dhawan; Kishor Raja; Robin D Hughes
Journal:  Cell Transplant       Date:  2010-11-19       Impact factor: 4.064

3.  Liver allograft radiotherapy to treat rejection in children: efficacy in orthotopic liver transplantation and long-term safety.

Authors:  Xavier Stephenne; Mustapha Najimi; Magda Janssen; Raymond Reding; Jean de Ville de Goyet; Etienne M Sokal
Journal:  Liver Int       Date:  2005-12       Impact factor: 5.828

Review 4.  Hepatocyte transplantation for liver-based metabolic disorders.

Authors:  Anil Dhawan; Ragai R Mitry; Robin D Hughes
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

5.  Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency.

Authors:  Xavier Stéphenne; Mustapha Najimi; Catherine Sibille; Marie-Cécile Nassogne; Françoise Smets; Etienne M Sokal
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up.

Authors:  Etienne M Sokal; Françoise Smets; Annick Bourgois; Lionel Van Maldergem; Jean-Paul Buts; Raymond Reding; Jean Bernard Otte; Veerle Evrard; Dominique Latinne; Marie Françoise Vincent; Anne Moser; Humberto E Soriano
Journal:  Transplantation       Date:  2003-08-27       Impact factor: 4.939

7.  One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects.

Authors:  Jochen Meyburg; Anibh M Das; Friederike Hoerster; Martin Lindner; Heinz Kriegbaum; Guido Engelmann; Jan Schmidt; Michael Ott; Andrea Pettenazzo; Thomas Luecke; Harald Bertram; Georg F Hoffmann; Alberto Burlina
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

8.  Human hepatocyte isolation and relationship of cell viability to early graft function.

Authors:  Ragai R Mitry; Robin D Hughes; Marion M Aw; Claire Terry; Giorgina Mieli-Vergani; Raffaele Girlanda; Paolo Muiesan; Mohamed Rela; Nigel D Heaton; Anil Dhawan
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

9.  Extended criteria donors in liver transplantation: adapting donor quality and recipient.

Authors:  M Gastaca
Journal:  Transplant Proc       Date:  2009-04       Impact factor: 1.066

10.  Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia.

Authors:  A A Khan; N Parveen; V S Mahaboob; A Rajendraprasad; H R Ravindraprakash; J Venkateswarlu; P Rao; G Pande; M Lakshmi Narusu; M N Khaja; R Pramila; A Habeeb; C M Habibullah
Journal:  Transplant Proc       Date:  2008-05       Impact factor: 1.066

View more
  3 in total

1.  Clinical Hepatocyte Transplantation: What Is Next?

Authors:  James E Squires; Kyle A Soltys; Patrick McKiernan; Robert H Squires; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Curr Transplant Rep       Date:  2017-10-14

2.  High Dose Versus Low Dose Syngeneic Hepatocyte Transplantation in Pex1-G844D NMRI Mouse Model is Safe but Does Not Achieve Long Term Engraftment.

Authors:  Tanguy Demaret; Jonathan Evraerts; Joachim Ravau; Martin Roumain; Giulio G Muccioli; Mustapha Najimi; Etienne M Sokal
Journal:  Cells       Date:  2020-12-30       Impact factor: 6.600

Review 3.  Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions.

Authors:  Ellen L Mitchell; Zahida Khan
Journal:  Curr Pathobiol Rep       Date:  2017-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.